Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$150 Mln
P/E Ratio
--
P/B Ratio
6.08
Industry P/E
--
Debt to Equity
0.33
ROE
-0.37 %
ROCE
-29.16 %
Div. Yield
0 %
Book Value
0.64
EPS
-0.16
CFO
$-70.17 Mln
EBITDA
$-70.44 Mln
Net Profit
$-85.95 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Myomo (MYO)
| -30.28 | -16.54 | -25.04 | 40.75 | 10.59 | 2.24 | -- |
|
BSE Sensex*
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Myomo (MYO)
| 28.28 | 880.43 | -92.53 | 1.71 | -25.42 | -79.11 | -61.40 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.28 | 10,289.47 | 14.38 | 12.69 | |
| 70.06 | 9,544.04 | 92.52 | 2.52 | |
| 152.07 | 8,064.21 | -- | -25.23 | |
| 277.22 | 10,728.90 | 773.26 | 1.2 |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled... upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts. Address: 45 Blue Sky Dr., Burlington, MA, United States, 01803 Read more
Chairman, President & CEO
Mr. Paul R. Gudonis
Chairman, President & CEO
Mr. Paul R. Gudonis
Headquarters
Burlington, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Myomo Inc (MYO) stood at $ 42 Mln as on 31-Dec-24
The share price of Myomo Inc (MYO) is $4.49 (NYSE) as of 22-Apr-2025 16:10 EDT. Myomo Inc (MYO) has given a return of 10.59% in the last 3 years.
Myomo Inc (MYO) has a market capitalisation of $ 150 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Myomo Inc (MYO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Myomo Inc (MYO) and enter the required number of quantities and click on buy to purchase the shares of Myomo Inc (MYO).
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts. Address: 45 Blue Sky Dr., Burlington, MA, United States, 01803
The CEO & director of Mr. Paul R. Gudonis. is Myomo Inc (MYO), and CFO & Sr. VP is Mr. Paul R. Gudonis.
There is no promoter pledging in Myomo Inc (MYO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Myomo Inc. (MYO) | Ratios |
|---|---|
|
Return on equity(%)
|
-36.69
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
-19
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Myomo Inc (MYO) was $0 Mln.
$0.21
(
